4172.TWO
Price:
$21.15
Market Cap:
$2.28B
InnoPharmax Inc., a specialty pharmaceutical company, develops and commercializes products for the treatment of oncology and other specialties in Taiwan. The company's core products include N11005, a prandial oral insulin; and GemOral. It also offers Imipenem and Cilastatin solution for the treatment of infections caused by susceptible organisms, such as lower respiratory tract, skin and skin structure, intra-abdominal, gynecologic, bone, and joint infections; contrast agents consisting of gadopentetate dimeglumine and gadodiamide; oncology agents comprising Innomustine and Immurin; and Inpheno tablets for rare diseases. In addition, the company provides MUCR system, OralPas, and OralPas Pro...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-09-13
Stock Exchange
TWO
Ticker
4172.TWO
According to InnoPharmax Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -20.34. This represents a change of 127.19% compared to the average of -8.95 of the last 4 quarters.
The mean historical PE Ratio of InnoPharmax Inc. over the last ten years is -17.22. The current -20.34 PE Ratio has changed 11.71% with respect to the historical average. Over the past ten years (40 quarters), 4172.TWO's PE Ratio was at its highest in in the December 2022 quarter at -4.55. The PE Ratio was at its lowest in in the June 2023 quarter at -21.94.
Average
-17.22
Median
-16.01
Minimum
-29.61
Maximum
-9.63
Discovering the peaks and valleys of InnoPharmax Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 207.31%
Maximum Annual PE Ratio = -9.63
Minimum Annual Increase = -45.75%
Minimum Annual PE Ratio = -29.61
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -15.95 | -28.87% |
| 2023 | -22.42 | 132.83% |
| 2022 | -9.63 | -40.05% |
| 2021 | -16.06 | -45.75% |
| 2020 | -29.61 | 207.31% |
The current PE Ratio of InnoPharmax Inc. (4172.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-16.00
5-year avg
-18.74
10-year avg
-17.22
InnoPharmax Inc.’s PE Ratio is less than Winston Medical Supply Co., Ltd. (12.77), greater than LIWANLI Innovation Co., Ltd. (-78.49), less than TSH Biopharm Corporation Limited (18.67), less than Golden Biotechnology Corporation (-15.69), greater than Allied Biotech Corporation (-41.90), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-20.23), greater than GeneFerm Biotechnology Co., Ltd. (-2565.71), greater than Advagene Biopharma Co., Ltd. (-24.47), greater than Shangya Technology Co., Ltd. (-32.10), less than Sunny Pharmtech Inc. (-7.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| 12.77 | $1.71B | |
| -78.49 | $1.91B | |
| 18.67 | $2.13B | |
| -15.69 | $5.56B | |
| -41.90 | $2.36B | |
| -20.23 | $1.92B | |
| -2565.71 | $1.94B | |
| -24.47 | $1.74B | |
| -32.10 | $2.06B | |
| -7.79 | $2.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoPharmax Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InnoPharmax Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is InnoPharmax Inc.'s PE Ratio?
How is the PE Ratio calculated for InnoPharmax Inc. (4172.TWO)?
What is the highest PE Ratio for InnoPharmax Inc. (4172.TWO)?
What is the 3-year average PE Ratio for InnoPharmax Inc. (4172.TWO)?
What is the 5-year average PE Ratio for InnoPharmax Inc. (4172.TWO)?
How does the current PE Ratio for InnoPharmax Inc. (4172.TWO) compare to its historical average?